Primary tabs

Novel Mouse Models for Testing HIV and HCV Vaccines

Hepatitis C virus (HCV) is a major cause of liver diseases, including cirrhosis and liver cancer. Treatment for chronic hepatitis C is often out of financial reach for people in developing countries, and there is no vaccine against the virus. To prepare a human vaccine, investigators need an animal model that can help them screen and prioritize vaccine candidates. Dr. Balling's team, partnering with Dr. Di Santo's group at the Institut Pasteur in France, is working toward the development of mice with livers and immune systems that are similar to those of humans. These animals might be used to test vaccines for HCV, and potentially, other human pathogens.

Grant ID
OPP37869
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
10324113.00
Funding Currency
USD
Funding Amount (in USD)
10324113.00
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
10324113.00
Co-Funded
False